Goldman Sachs Downgrades Forest Laboratories (FRX) to Sell

Article Stock Quotes (1) Comments (0)

Goldman Sachs downgraded Forest Laboratories (NYSE: FRX) from Neutral to Sell with a price target of $33 (down form $35).

The firm said new launches of Viibryd/Daliresp are unlikely to exceed expectations. In addition, the firm sees deceleration for key in-line products (Namenda, Savella), large exclusivity losses (Lexapro, Namenda), and negative operating leverage

For more ratings news on Forest Laboratories click here and for the rating history of Forest Laboratories click here.

Shares of Forest Laboratories closed at $33.18 yesterday, with a 52 week range of $30.03-$40.52.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
• UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
• UPDATE: Sidoti Downgrades Texas Industries (TXI) to Neutral

Create E-mail Alert Related Categories

Downgrades, Hot Downgrades

Related Entities

Goldman Sachs

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?